Christine Chevreau - Concepedia

Author

Christine Chevreau

Also Known As

C CHEVREAU, C Chevreau, C Chevreau , C. CHEVREAU, C. Chevreau, C.M. Chevreau, CHRISTINE CHEVREAU, Chevreau, Christine, Christine CHEVREAU, Christine Chevreau

493

Publications

27.8K

Citations

H-Index

127

Concepts

All Affiliations

Institut Claudius Regaud Institut Gustave Roussy Centre Léon Bérard Institut Bergonié Centre Oscar Lambret

About

Christine Chevreau is an author at Institut Claudius Regaud specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	118	9.7K
2	Health Sciences	14	20	1.1K
3	Cell Biology	4	4	118
4	Biostatistics	3	3	239
5	Education	1	1	61

Christine Chevreau

205

Publications

25.7K

Citations

H-Index

Page 1

	Year	Citations
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Bernard Escudier, Tim Eisen, Walter M. Stadler, New England Journal of Medicine	2007	4.8K
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Bernard Escudier, P. Koralewski, Alain Ravaud, The Lancet UrologySurgical OncologyOncologyGenitourinary CancerInterferon Alfa-2a	2007	2.2K
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Bernard Escudier, Tim Eisen, Walter M. Stadler, Journal of Clinical Oncology	2009	1.1K
Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma Sylvie Négrier, Bernard Escudier, Christine Lasset, New England Journal of Medicine	1998	965
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma Arnaud Méjean, Alain Ravaud, Simon Thézenas, New England Journal of Medicine	2018	909
Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience Andrés J.M. Ferreri, Jean‐Yves Blay, Michele Reni, Journal of Clinical Oncology	2003	824
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, New England Journal of Medicine	2021	708
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study Nicolas Penel, Binh Bui, Jacques‐Olivier Bay, Journal of Clinical Oncology	2008	683
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987 Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, Journal of Clinical Oncology	2012	529
Improved survival using specialized multidisciplinary board in sarcoma patients Jean‐Yves Blay, Pauline Soibinet, Nicolas Penel, Annals of Oncology Surgical OncologySpecialized Multidisciplinary BoardMedicineCancer ManagementPrognosis	2017	349

Page 1